Mesenchymal Stem Cells in the Treatment of Type I Diabetes Mellitus
William Shank Introduction. Type I diabetes mellitus (T1D) is a chronic disease characterized by autoimmune destruction of pancreatic β-cells leading to chronic insufficient insulin production. Lymphocytic infiltration and destruction of these cells, along with circulating islet cell antibodies and anti-insulin antibodies are seen in T1D patients1,2. Treatment of T1D currently…